Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

Creative Commons License

Pamukeu H. E., GEREDE ULUDAĞ D. M., Tak B. T., SORGUN M. H., Efe T. H., Acibuca A., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.20, sa.4, ss.213-219, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.14744/anatoljcardiol.2018.65983
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.213-219
  • Anahtar Kelimeler: Parkinson's disease, non-ergot dopamine agonist, speckle tracking echocardiography, strain echocardiography, VALVULAR HEART-DISEASE, PARKINSONS-DISEASE, VALVE REGURGITATION, FAILURE, PERGOLIDE, ERGOT, RISK, DYSAUTONOMIA, FENFLURAMINE, DEFORMATION
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Parkinson's disease (PD) is a neurological disorder, and ergot dopamine agonists (DAs) are no longer usually preferred in the treatment due to the increased risk of valvular heart disease. Some recent studies have shown that commonly used non-ergot DA also increases the risk of heart failure. On the other hand, there are studies showing conflicting data about this relationship. The aim of the present study was to investigate the cardiac effects of non-ergot DAs in patients with PD using echocardiography.